Osang Healthcare Co.,Ltd
Osang Healthcare Co.,Ltd researches, develops, and sells various diagnostic biosensors in South Korea and internationally. The company offers diagnostic biosensors for blood glucose, hemoglobin A1c, cholesterol, immuno diagnosis, molecular diagnosis, and others. It also exports its products to approximately 110 countries worldwide. The company was formerly known as Infopia Co., Ltd. and changed i… Read more
Osang Healthcare Co.,Ltd (036220) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2024: -0.122x
Based on the latest financial reports, Osang Healthcare Co.,Ltd (036220) has a cash flow conversion efficiency ratio of -0.122x as of September 2024.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-34.00 Billion) by net assets (₩277.86 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Osang Healthcare Co.,Ltd - Cash Flow Conversion Efficiency Trend (2022–2024)
This chart illustrates how Osang Healthcare Co.,Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Osang Healthcare Co.,Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Osang Healthcare Co.,Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
InspireMD Inc
NASDAQ:NSPR
|
-0.135x |
|
China Everbright Greentech Limited
F:CK7
|
-0.006x |
|
Vaccibody AS
F:5VB
|
-0.061x |
|
Banestes S.A - Banco do Estado do Espírito Santo
SA:BEES3
|
-1.747x |
|
Index Living Mall Public Company Limited
BK:ILM
|
0.084x |
|
Pinar Sut Mamulleri Sanayi AS
IS:PNSUT
|
0.025x |
|
Tobii AB
PINK:TBIIF
|
0.228x |
|
Kolon Global Corp
KO:003075
|
-0.036x |
Annual Cash Flow Conversion Efficiency for Osang Healthcare Co.,Ltd (2022–2024)
The table below shows the annual cash flow conversion efficiency of Osang Healthcare Co.,Ltd from 2022 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩285.75 Billion | ₩-38.77 Billion | -0.136x | -126.09% |
| 2023-12-31 | ₩293.03 Billion | ₩152.36 Billion | 0.520x | +144.34% |
| 2022-12-31 | ₩199.86 Billion | ₩42.53 Billion | 0.213x | -- |